Brief: Kiromic Biopharma Inc Announces Strategic Collaboration With Gemelli Teaching Hospital
11/10/2021 13:11
Oct 11 (Reuters) - Kiromic Biopharma Inc KRBP.O :
* KIROMIC BIOPHARMA ANNOUNCES STRATEGIC COLLABORATION WITH
GEMELLI
TEACHING HOSPITAL TO ACCELERATE THE ANALYSIS OF ALLOGENEIC CAR-T
CLINICAL TRIAL CANDIDATE ALEXIS ISO-1 IN SOLID CANCERS
* KIROMIC BIOPHARMA - STRATEGIC COLLABORATION WITH GEMELLI
TEACHING HOSPITAL IRCCS TO ACCELERATE ANALYSIS OF ALEXIS ISO-1
* KIROMIC BIOPHARMA - ANTICIPATE BEING GRANTED A TYPE A
MEETING
WITH FDA BY FIRST HALF OF 2022
* KIROMIC BIOPHARMA - ANTICIPATING BEING GRANTED TYPE A
MEETING
WITH FDA BY H1 2022 TO DISCUSS CLINICAL HOLD & CLINICAL
DEVELOPMENT PATH FORWARD OF IND
* KIROMIC BIOPHARMA - FOLLOWING TYPE A MEETING, COMPANY
PLANS TO
RESUBMIT INVESTIGATIONAL NEW DRUG (IND) APPLICATION
Source text for Eikon: ID:nBw6KkYDSa
Further company coverage: KRBP.O
Recent news on Kiromic Biopharma
See all newsBrief: Kiromic Biopharma Files For Offering Up To 1 Million Units
Brief: Kiromic Biopharma Applies To List Common Stock On The NYSE American Under Symbol 'KRBP'
Brief: Kiromic Biopharma Advances Deltacel-01 Into Expansion Phase Following Safety Monitoring Committee's Unanimous Recommendation
Brief: Kiromic Biopharma Reports Favorable Results At Six Weeks From Fourth Patient In Deltacel-01 Clinical Trial
Brief: Kiromic BioPharma Adds UPMC as Fourth Deltacel-01 Clinical Trial Site